Evogene Q2 2025 Earnings Preview: EPS and Revenue Estimates Ahead of August 19th Release

Evogene is set to announce Q2 2025 earnings on August 19th. The consensus EPS estimate is -$0.63, a 40.6% YoY increase, while the revenue estimate is $0.93M, a 2.2% YoY increase. Over the past two years, Evogene has reported an average EPS of -$0.36 and an average revenue of $0.92M.

Evogene (NASDAQ:EVGN) is scheduled to announce its Q2 2025 earnings results on Tuesday, August 19, before the market opens. The consensus earnings per share (EPS) estimate stands at -$0.63, representing a 40.6% year-over-year (YoY) increase, while the consensus revenue estimate is $0.93 million, a 2.2% YoY increase [1].

Over the past two years, Evogene has shown a consistent trend of beating EPS estimates, with a success rate of 75% and a revenue estimate beat rate of 63% [1]. In Q1 2025, the company reported an EPS of -$0.38, which exceeded analysts' consensus estimates by $0.12, while revenue was $2.44 million, below the consensus estimate of $4.42 million [2].

The upcoming earnings announcement is expected to provide insights into Evogene's financial performance for the second quarter of 2025. Investors will be closely watching for any updates on the company's strategic initiatives, financial health, and future growth prospects. The conference call is scheduled for 9:00 AM ET on August 19, with transcripts and audio expected to be available shortly thereafter [2].

References:
[1] https://seekingalpha.com/news/4486643-evogene-q2-2025-earnings-preview
[2] https://www.marketbeat.com/stocks/NASDAQ/EVGN/earnings/